A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Patients With IgA Nephropathy

被引：0

作者：

Rizk, Dana ^{[1
]}

Perkovic, Vlado ^{[2
]}

Lafayette, Richard A. ^{[3
]}

Trimarchi, Hernan ^{[4
]}

Barratt, Jonathan ^{[5
]}

Carroll, Kevin ^{[6
]}

Tesar, Vladimir ^{[7
]}

Zhang, Hong ^{[8
]}

Suzuki, Yusuke ^{[9
]}

Liew, Adrian ^{[10
]}

Wong, Muh Geot ^{[11
]}

Leslie, Bruce R. ^{[12
]}

Mathur, Mohit ^{[13
]}

Hafkin, Jeffrey ^{[12
]}

机构：

[1] Univ Alabama Birmingham, Birmingham, AL USA

[2] Univ New South Wales, Sydney, NSW, Australia

[3] Stanford Univ, Stanford, CA USA

[4] Hosp Britanico Buenos Aires, Buenos Aires, DF, Argentina

[5] Univ Leicester, Leicester, Leics, England

[6] KJC Stat, London, England

[7] Charles Univ Prague, Prague, Czech Republic

[8] Peking Univ, Beijing, Peoples R China

[9] Juntendo Daigaku, Bunkyo Ku, Tokyo, Japan

[10] Mt Elizabeth Novena Hosp, Singapore, Singapore

[11] Concord Repatriat Gen Hosp, Concord, NSW, Australia

[12] Otsuka Pharmaceut Dev Commercializat Inc, Rockville, MD USA

[13] Visterra Inc, Boston, MA USA

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

SA-PO712

引用

页码：799 / 799

页数：1

共 50 条

[1] Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
Chen, Qi
Wang, Zi
Lv, Jicheng
Liu, Lijun
Li, Hang
Sun, Weiwei
Huo, Yanhong
Guo, Yingbo
Shen, Cun
Li, Shichao
Chen, Zhenjie
Zhou, Jingwei
[J]. TRIALS, 2022, 23 (01)
[2] Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
Qi Chen
Zi Wang
Jicheng Lv
Lijun Liu
Hang Li
Weiwei Sun
Yanhong Huo
Yingbo Guo
Cun Shen
Shichao Li
Zhenjie Chen
Jingwei Zhou
[J]. Trials, 23
[3] THE APPROACH STUDY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY OF VOLANESORSEN ADMINISTERED SUBCUTANEOUSLY TO PATIENTS WITH FCS
Gaudet, Daniel
Digenio, Andres
Alexander, Veronica J.
Arca, Marcello
Jones, Alan F.
Stroes, Erik
Bergeron, Jean
Civeira, Fernando
Hemphill, Linda C.
Blom, Dirk J.
Flaim, Joann
Hughes, Steven
Geary, Richard
Tsimikas, Sotirios
Bruckert, Eric
[J]. ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 14 - +
[4] Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study
Gupta, Pawan Kumar
Maheshwari, Sunil
Cherian, Joe Joseph
Goni, Vijay
Sharma, Arun Kumar
Tripathy, Sujith Kumar
Talari, Keerthi
Pandey, Vivek
Sancheti, Parag Kantilal
Singh, Saurabh
Verma, Nikhil N.
Kumar, Uday
[J]. AMERICAN JOURNAL OF SPORTS MEDICINE, 2023, 51 (09): : 2254 - 2266
[5] A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis
Wolfgang A. Schmidt
Bhaskar Dasgupta
Jennifer Sloane
Angeliki Giannelou
Yuqing Xu
Sebastian H. Unizony
Sarah L. Mackie
Miguel A. Gonzalez-Gay
Robert Spiera
Kenneth J. Warrington
Peter M. Villiger
Michael C. Nivens
Bolanle Akinlade
Yong Lin
Frank Buttgereit
John H. Stone
[J]. Arthritis Research & Therapy, 25
[6] A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis
Schmidt, Wolfgang A.
Dasgupta, Bhaskar
Sloane, Jennifer
Giannelou, Angeliki
Xu, Yuqing
Unizony, Sebastian H.
Mackie, Sarah L.
Gonzalez-Gay, Miguel A.
Spiera, Robert
Warrington, Kenneth J.
Villiger, Peter M.
Nivens, Michael C.
Akinlade, Bolanle
Lin, Yong
Buttgereit, Frank
Stone, John H.
[J]. ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
[7] A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia
Hiroyoshi Ohta
Hiroshi Oka
Chie Usui
Masayuki Ohkura
Makoto Suzuki
Kusuki Nishioka
[J]. Arthritis Research & Therapy, 14
[8] A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia
Ohta, Hiroyoshi
Oka, Hiroshi
Usui, Chie
Ohkura, Masayuki
Suzuki, Makoto
Nishioka, Kusuki
[J]. ARTHRITIS RESEARCH & THERAPY, 2012, 14 (05)
[9] Efficacy and Safety of Letibotulinumtoxin A in the Treatment of Glabellar Lines: A Randomized, Double-blind, Multicenter, Placebo-Controlled Phase 3 Study
Mueller, Daniel S.
Prinz, Valentina
Adelglass, Jeffrey
Cox, Sue Ellen
Gold, Michael H.
Kaufman-Janette, Joely
Nestor, Mark S.
Taylor, Susan
Frank, Konstantin
[J]. AESTHETIC SURGERY JOURNAL, 2022, 42 (06) : 677 - 688
[10] Trial in Progress: Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients with Cold Agglutinin Disease (CASCADE)
Jilma, Bernd
Roman, Eloy
Ueda, Yasutaka
Mappa, Silvia
Szamosi, Johan
Savage, Jessica
Roeth, Alexander
[J]. BLOOD, 2022, 140 : 5326 - 5327

← 1 2 3 4 5 →